EICHOR
● Terminated
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Condition: Atopic Dermatitis · Sponsor: Amgen
About this study
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (547)
| Cahaba Dermatology and Skin Health Center | Birmingham, Alabama, United States | — |
| Medical Dermatology Specialists | Phoenix, Arizona, United States | — |
| Alliance Dermatology and Mohs Center | Phoenix, Arizona, United States | — |
| Affiliated Dermatology | Scottsdale, Arizona, United States | — |
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | — |
| Dermatology Trial Associates | Bryant, Arkansas, United States | — |
| Burke Pharmaceutical Research | Hot Springs, Arkansas, United States | — |
| Arkansas Research Trials, LLC | North Little Rock, Arkansas, United States | — |
| Kern Research Inc | Bakersfield, California, United States | — |
| Hope Clinical Research LLC | Canoga Park, California, United States | — |
| West Coast Research LLC | Dublin, California, United States | — |
| California Dermatology and Clinical Research Institute | Encinitas, California, United States | — |
+ 535 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05882877